Differences in β-adrenergic receptor densities in omental and subcutaneous adipose tissue from obese African American and Caucasian women

被引:12
作者
McConnaughey, MM
Sheets, KA
Davis, J
Privette, J
Hickner, R
Christian, B
Barakat, H [1 ]
机构
[1] E Carolina Univ, Dept Med, Brody Sch Med, Greenville, NC 27858 USA
[2] E Carolina Univ, Dept Pharmacol, Brody Sch Med, Greenville, NC 27858 USA
[3] E Carolina Univ, Dept Physiol, Brody Sch Med, Greenville, NC 27858 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2004年 / 53卷 / 02期
关键词
D O I
10.1016/j.metabol.2003.09.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
African American women lose less weight and at a slower rate than Caucasian women under the same weight loss conditions. This is likely due to decreased mobilization of fat, possibly involving differences in the responsiveness of adipose tissue to adrenergic stimulation. To better understand the causes behind the decreased lipolysis in African American women, this study was initiated to determine if there were differences in the numbers and affinities of beta adrenoreceptors in omental and subcutaneous adipose tissue of obese African American and Caucasian women. We determined the number of 13 receptors using a nonselective antagonist and found the total number of receptors in both omental and subcutaneous adipose tissue preparations were higher in African American than Caucasian women. 01,132, and 133 densities were higher in omental adipose tissue (P < .05), but not different in the subcutaneous tissue of the African American women. No racial differences in kd values for adrenergic agents (agonists and antagonists) were found with regard to beta(1), beta(2), or beta(3) receptors in either the omental or the subcutaneous preparations. beta(1) and beta(2) receptor protein (mass) was significantly increased in African American omental tissue preparations, but not subcutaneous. Our in vitro data demonstrating increased beta receptor numbers in omental tissue from obese African Americans suggest that the potential for lipolysis would be higher in these women. Future studies should determine the biologic significance of the differences in the beta adrenergic receptors in vivo. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 37 条
[11]  
BURKE GL, 1989, INT J EPIDEMIOL, V18, pS73
[12]  
Candelore MR, 1999, J PHARMACOL EXP THER, V290, P649
[13]   ANTILIPOLYTIC EFFECTS OF ALPHA(2)-ADRENERGIC AGONISTS, NEUROPEPTIDE-Y, ADENOSINE, AND PGE(1) IN MAMMAL ADIPOCYTES [J].
CASTAN, I ;
VALET, P ;
QUIDEAU, N ;
VOISIN, T ;
AMBID, L ;
LABURTHE, M ;
LAFONTAN, M ;
CARPENE, C .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :R1141-R1147
[14]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[15]  
Darga L L, 1994, Obes Res, V2, P239
[16]   ROLE OF VASCULAR ALPHA-2-ADRENOCEPTORS IN REGULATING LIPID MOBILIZATION FROM HUMAN ADIPOSE-TISSUE [J].
GALITZKY, J ;
LAFONTAN, M ;
NORDENSTROM, J ;
ARNER, P .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) :1997-2003
[17]   MECHANISMS FOR DIFFERENCES IN LIPOLYSIS BETWEEN HUMAN SUBCUTANEOUS AND OMENTAL FAT-CELLS [J].
HELLMER, J ;
MARCUS, C ;
SONNENFELD, T ;
ARNER, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (01) :15-20
[18]   A new paradigm for type 2 diabetes mellitus - Could it be a disease of the foregut? [J].
Hickey, MS ;
Pories, WJ ;
MacDonald, KG ;
Cory, KA ;
Dohm, GL ;
Swanson, MS ;
Israel, RG ;
Barakat, HA ;
Considine, RV ;
Caro, JF ;
Houmard, JA .
ANNALS OF SURGERY, 1998, 227 (05) :637-644
[19]   Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus [J].
Ishiyama-Shigemoto, S ;
Yamada, K ;
Yuan, X ;
Ichikawa, F ;
Nonaka, K .
DIABETOLOGIA, 1999, 42 (01) :98-101
[20]  
Kemper K A, 1994, Obes Res, V2, P117